Incoming Rx Intern Industry Slowdown Concerns

Hi all,

I'm an incoming Rx Consulting intern at a Big 3 Rx firm (FTI/A&M/AlixPartners) as a junior in undergrad. I'm very, very fortunate to have this opportunity but can't help and think about full-time conversion returns. 

I'm sure over the last year or so, hiring for restructuring/turnaround was very necessary and so more likely than not many firms began increasing recruiting. Now, based off Rx slowdown, it seems that there is a lot of pitching and not a ton of work to be done (or as much as last year). Should this be something to concern myself with?

It would be nice to see how people think this'll impact full-time. Does anyone have any advice for this situation? Would it be recommended to begin/continue networking with individuals in the Rx space (i.e. speak to Rx IBs, other Rx consulting firms, even something like McKinsey RTS, BCG TURN, e.t.c.)?

Really appreciate all the help and insight! 

*Posting this in both consulting and IB in case Rx bankers and others have suggestions

5 Comments
 

I work in Rx/distressed space - wouldn't be concerned. If anything, they will extend less 3rd year offers in the future to make room for your class (not sure if this is the same in consulting). Given the SPAC boom, there's still a lot of work expected around the corner, even if it's requiring a bit more creativity these days. I'd still recommend pursuing Rx if it's of interest to you. When cycles turn, it's a lot easier to go from Rx to M&A than the other way around. 

That being said, I am seeing some headcount reductions at some distressed buyside shops, and some others having to flex mandates to deploy capital; however, you're still a ways off and wouldn't worry about that. Good luck!

 

Officiis maiores deserunt voluptas aut quod possimus. Et placeat hic nesciunt id magni aliquid porro ea. Rem tempore molestiae sapiente non fugit ut et. Exercitationem voluptatem consequuntur atque labore officiis.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”